Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Title Deadline Approaching for CSI Compressco Stockholders to Qualify for Dividend Payout

Elaine Mendonca by Elaine Mendonca
January 26, 2024
in Breaking News
0
Renewable energy
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Investors have until Monday, January 25, 2024, to seize the opportunity to purchase CSI Compressco (NASDAQ:CCLP) stock and qualify for the upcoming dividend payout. The company has recently declared a quarterly dividend of 1 cent per share, scheduled to be distributed to shareholders on February 14, 2024. In order to be eligible for this dividend, investors must possess the stock before the ex-dividend date, which falls on Tuesday. Those who hold CCLP shares by the end of Monday’s trading session will be entitled to receive the 1 cent dividend payout for each share they own.

CSI Compressco LP has a consistent track record of delivering quarterly dividends, with the most recent ex-dividend date occurring on October 27, 2023. The company’s annual dividend amounts to $0.04, resulting in a dividend yield of 2.26%.

Investors will have the flexibility to either reinvest their dividends back into the stock or utilize the payment in alternative ways. It is crucial for investors to stay informed about ex-dividend dates and other significant dividend-related dates to make well-informed decisions regarding their investments.

Promising Signs for Investors: CCLP Stock Shows Strong Performance and Positive Price Momentum on January 25, 2024

On January 25, 2024, CCLP stock displayed a strong performance, showing promising signs for investors. According to data sourced from CNN Money, CCLP was trading in the middle of its 52-week range and above its 200-day simple moving average, indicating positive price momentum.

The price of CCLP shares experienced a notable increase of $0.07 since the market closed, representing a rise of 3.87%. This surge in price demonstrates a bullish sentiment among investors, as they anticipate further growth and potential returns. CCLP closed at $1.88, reflecting the positive market sentiment on that day.

Moreover, the stock continued its upward trajectory in after-hours trading, with an additional increase of $0.01. This after-hours gain further solidifies the positive momentum and suggests that investors are optimistic about the future prospects of CCLP.

The fact that CCLP is trading above its 200-day simple moving average is particularly encouraging. This moving average is a commonly used technical indicator that helps investors identify the overall trend of a stock. When a stock is trading above its 200-day moving average, it suggests that the stock is in an uptrend and has the potential for further gains.

Furthermore, being in the middle of its 52-week range indicates that CCLP has not reached its highest point over the past year, leaving room for potential growth. This can be an attractive prospect for investors looking to capitalize on the stock’s upward momentum.

Investors should note that while the performance of CCLP on January 25, 2024, was positive, it is essential to conduct thorough research and analysis before making any investment decisions. Stock prices can be influenced by various factors, including market conditions, company performance, and economic indicators. Therefore, it is crucial to consider these factors and consult with a financial advisor to make informed investment choices.

In conclusion, CCLP stock demonstrated a strong performance on January 25, 2024, with an increase of $0.07 since the market closed, representing a rise of 3.87%. Trading above its 200-day simple moving average and in the middle of its 52-week range, CCLP exhibited positive price momentum and potential for further growth. However, investors should exercise caution and conduct thorough research before making any investment decisions.

Strong Stock Performance: CCLP Reports Impressive Financial Results on January 25, 2024

CCLP Stock Shows Strong Performance on January 25, 2024

CCLP, a leading company in the industry, showcased impressive stock performance on January 25, 2024. The stock’s success can be attributed to its strong financial results, which were reflected in its total revenue, net income, and earnings per share (EPS).

According to data sourced from CNN Money, CCLP reported a total revenue of $353.40 million over the past year, representing a significant increase of 16.18% compared to the previous year. Additionally, the company’s total revenue for the third quarter stood at $99.71 million, reflecting a 3.03% increase since the previous quarter.

Furthermore, CCLP’s net income also showed remarkable improvement. The company reported a net loss of -$22.16 million over the past year, which has now reduced to -$943.00 thousand in the third quarter. This represents a substantial increase of 54.85% compared to the previous year and a notable increase of 63.18% since the last quarter.

Moreover, CCLP’s earnings per share (EPS) also witnessed significant growth. The EPS for the past year stood at -$0.16, which has now increased to -$0.01 in the third quarter. This represents a substantial increase of 80.46% since the previous year and a notable increase of 63.33% since the last quarter.

In conclusion, CCLP showcased strong stock performance on January 25, 2024, driven by impressive financial results. The company experienced significant growth in total revenue, net income, and earnings per share. These positive indicators highlight CCLP’s ability to generate sales, improve profitability, and potentially provide returns for its shareholders. Investors should keep a close eye on CCLP’s future performance as the company continues to demonstrate its financial strength and potential for growth.

Tags: CCLP
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Renewable energy

Barclays Analyst Upgrades Icons Price Target Remains Positive

Government Stock Bull Market

Northern Technologies Announces Quarterly Dividend and ExDividend Date

Commercial Vehicles and Trucks Stock Exchange

Opportunity to Acquire MetroCity Bankshares Shares Before ExDividend Date

Recommended

FITB stock news

Davenport & Co LLC Boosts Stake in Starwood Property Trust, Inc.: A Resilient REIT Positioned for Growth

3 years ago
AT&T Stock

AT&T Bets Big on Network Transformation with Massive Infrastructure Push

5 months ago
Dominion Energy Stock

Dominion Energy Faces Critical Earnings Test Amid Diverging Metrics

3 months ago
Riot Blockchain Stock

Riot Blockchain Stock: Riding the Bitcoin Mining Momentum

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

Fossil Group Stock Surges Past Key Technical Threshold

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

Arcus Biosciences Pivots Pipeline Strategy Following Clinical Setback

Trending

Viking Therapeutics Stock
Analysis

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

by Dieter Jaworski
February 5, 2026
0

Shares of Viking Therapeutics are trading within a consolidated range as the market anticipates significant corporate news....

Solana Stock

Solana Faces Billions in Potential Token Supply Releases

February 5, 2026
CureVac Stock

CureVac Delisted Following BioNTech Acquisition Completion

February 5, 2026
EOS Stock

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

February 5, 2026
NexPoint Residential Stock

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

February 4, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report
  • Solana Faces Billions in Potential Token Supply Releases
  • CureVac Delisted Following BioNTech Acquisition Completion

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com